CLL – The New Era
Welcome to the CLL Global Research Foundation web site. Our goal is to eliminate chronic lymphocytic leukemia (CLL) as a threat to life by funding outstanding research aimed at eradicating this disease.
Dr. Michael Keating, professor of medicine at MD Anderson Cancer Center, serves as president and CEO of the CLL Global Research Foundation. He is an internationally renowned CLL clinical scientist dedicated to patient care and to development of potentially curative CLL therapies.